Sono-Tek receives $5 million order for medical device coating systems

MILTON, N.Y. - Sono-Tek Corporation (NASDAQ:SOTK), a developer and manufacturer of ultrasonic coating systems with a market capitalization of $52.69 million and robust financial health according to InvestingPro data, announced Wednesday it has received a purchase order valued at over $5 million for coating systems to be used in medical device production.

The order includes multiple MediCoat systems designed for high-precision manufacturing. Deliveries are scheduled to begin in 2026 and will be completed over approximately a 12-month period.

"This order reflects the growing adoption of Sono-Tek’s advanced coating platforms by leading medical device manufacturers worldwide," said Steve Harshbarger, President and CEO of Sono-Tek.

The company indicated the order aligns with its strategy of focusing on complex, high-value production systems with higher average selling prices while expanding across multiple markets.

Sono-Tek’s ultrasonic coating systems apply thin films onto parts used in various industries including microelectronics, alternative energy, medical devices, and advanced industrial manufacturing.

The medical sector represents a key growth area in the company’s long-term strategy, according to the press release statement.

In other recent news, Sono-Tek Corporation reported a significant development at its annual meeting of shareholders. Philip Strasburg, a longstanding member of the board of directors, did not stand for reelection, leading to the conclusion of his term. Additionally, Sono-Tek secured a substantial order valued at $1.12 million from a long-term client in the medical diagnostic testing sector. This client, a global manufacturer, has maintained a relationship with Sono-Tek for nearly a decade, previously acquiring over ten mid-size ultrasonic coating systems. These systems are typically priced between $110,000 and $150,000 each. The order underscores the ongoing collaboration between Sono-Tek and this key client, highlighting the company’s continued presence in the medical diagnostics industry. These developments reflect Sono-Tek’s active engagement in both corporate governance and business operations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.